Tubersol Market Report 2026

Tubersol Market Overview

• The Tubersol market growth in the historic period has been driven by longstanding reliance on tuberculin skin testing, widespread public health tb screening programs • Market expansion is supported by screening expansion in high-risk populations, rising government focus on tb elimination • Growth Driver: Increasing Tuberculosis Prevalence Drives Growth In The Market • North America was the largest region in 2025.

What Is Covered Under Tubersol Market?

Tubersol is a purified protein derivative (PPD) solution used in tuberculin skin tests (TST) to diagnose tuberculosis (TB) infection. It is injected under the skin, and the reaction at the injection site indicates whether an individual has been exposed to Mycobacterium tuberculosis. The main types of clinical indications in tubersol are tuberculosis screening, diagnosis of active tuberculosis, diagnosis of latent tuberculosis, and other respiratory diseases. Tuberculosis screening is the process of identifying individuals with latent or active TB infection through tests like the tuberculin skin test, blood assays, or chest X-rays to enable early detection and treatment. It is available in both single-dose and multi-dose vial formulations, and distributed through various channels such as hospitals and clinics, retail and specialty pharmacies, and online sales. It cater to various end users such as adult, geriatric, and pediatric.

What Is The Tubersol Market Growth Forecast?

The growth in the forecast period can be attributed to screening expansion in high-risk populations, rising government focus on tb elimination, improved access to diagnostic testing, expansion of occupational health screening, increased funding for infectious disease control. Major trends in the forecast period include increasing use of tuberculin skin testing programs, rising focus on early tb diagnosis, expansion of public health screening initiatives, growing demand for latent tb detection, enhanced standardization of diagnostic protocols.

Global Tubersol Market Segmentation

1) By Clinical Indication: Tuberculosis Screening, Diagnosis Of Active Tuberculosis, Diagnosis Of Latent Tuberculosis, Other Respiratory Diseases 2) By Formulation: Single-Dose Vials, Multi-Dose Vials 3) By Distribution Channel: Hospital And Clinics, Retail And Specialty Pharmacies, Online Sales 4) By End User: Adult, Geriatric, Pediatric

What Are The Drivers Of The Tubersol Market?

The increasing prevalence of tuberculosis is expected to propel the growth of the tubersol market going forward. Tuberculosis (TB) is a contagious bacterial infection caused by mycobacterium tuberculosis that primarily affects the lungs but can also impact other body parts. The increasing prevalence of tuberculosis can be attributed to factors such as co-infection with HIV/AIDS, drug resistance, globalization and migration, poor nutrition, crowded living conditions, limited access to healthcare, stigma, and poor ventilation. Tubersol is used in the tuberculin skin test (TST) to help detect latent tuberculosis infections by triggering an immune response to the purified protein derivative of the TB bacteria. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, representing a rise of 1,295 cases. Therefore, the increasing prevalence of tuberculosis drives growth in the tubersol industry. The rising government initiative for tuberculosis is expected to propel the growth of the tubersol market going forward. Tuberculosis (TB) is a contagious and potentially serious infectious disease primarily caused by the bacterium Mycobacterium tuberculosis. It usually affects the lungs (pulmonary tuberculosis), but it can also spread to other parts of the body, including the kidneys, spine, and brain (extrapulmonary TB). The rising government initiatives for tuberculosis are due to increased funding, policy support, and collaborative efforts to enhance TB diagnosis, treatment, and prevention, contributing to more effective disease control and improved public health outcomes. Government initiatives for tuberculosis, such as enhanced screening programs, funding for TB control, and global partnerships, stimulate the tubersol by increasing the demand for TB testing and diagnostic solutions. For instance, in October 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, in 2023, an annual investment of $22 billion is required for TB prevention, diagnosis, treatment, and care to achieve the global objectives set for 2027, with 80% of the funding expected to come from domestic sources. Therefore, the rising government initiative for tuberculosis drives growth in the tubersol industry. The development of healthcare infrastructure is expected to propel the growth of the tubersol market going forward. Healthcare infrastructure is the facilities, equipment, goods, and systems that support delivering healthcare services, ensuring effective and accessible medical care for individuals and communities. The development of healthcare infrastructure is due to advancing medical technologies, increasing healthcare demands, and government initiatives, leading to greater investments in modern facilities and improved healthcare access globally. Healthcare infrastructure drives the adoption of Tubersol by ensuring widespread availability, supporting skilled administration, and facilitating efficient distribution and integration into national TB control efforts. For instance, in May 2023, according to the American Health Care Association, a US-based nonprofit organization, the United States had 6,129 hospitals, representing a 0.591% increase from the previous year when there were 6,093 hospitals. Therefore, developing healthcare infrastructure is driving growth in the tubersol industry.

Key Players In The Global Tubersol Market

Major companies operating in the tubersol market are Sanofi S.A.

Regional Insights

North America was the largest region in the tubersol market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Tubersol Market?

The tubersol market consists of sales of syringes and needles, diagnostic reagents, refrigeration storage units, multi-dose vials, and purified protein derivative (PPD) injections. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Tubersol Market Report 2026?

The tubersol market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the tubersol industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.